Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_assertion type Assertion NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_head.
- NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_assertion wasGeneratedBy ECO_0000203 NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_provenance.
- NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_assertion wasDerivedFrom befree-20150227 NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_provenance.
- NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_assertion SIO_000772 21656078 NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_provenance.
- NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_assertion evidence source_evidence_literature NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_provenance.
- NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_assertion description "[Therefore, combined inhibition of COX-2 and 5-LO or CYP2J2 may be one way to overcome low efficacy of single inhibition of COX-2 in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343226.RAnXy73GIQyY5Z2FeeuUOtZzXmBi586UQymV9SaqPRg3o130_provenance.